International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(14), P. 8043 - 8043
Published: July 21, 2022
Chronic
kidney
disease
(CKD)
is
a
growing
global
public
health
problem.
The
implementation
of
evidence-based
clinical
practices
only
defers
the
development
failure.
Death,
transplantation,
or
dialysis
are
consequences
failure,
resulting
in
significant
burden
on
system.
Hence,
innovative
therapeutic
strategies
urgently
needed
due
to
limitations
current
interventions.
Photobiomodulation
(PBM),
form
non-thermal
light
therapy,
effectively
mitigates
mitochondrial
dysfunction,
reactive
oxidative
stress,
inflammation,
and
gut
microbiota
dysbiosis,
all
which
inherent
CKD.
Preliminary
studies
suggest
benefits
PBM
multiple
diseases,
including
this
review
will
provide
concise
summary
underlying
action
mechanisms
its
potential
effects
Based
findings,
may
represent
novel,
non-invasive
non-pharmacological
therapy
for
CKD,
although
more
necessary
before
can
be
widely
recommended.
Translational Psychiatry,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Jan. 9, 2023
Abstract
Mood
disorders
are
associated
with
elevated
inflammation,
and
the
reduction
of
symptoms
after
multiple
treatments
is
often
accompanied
by
pro-inflammation
restoration.
A
variety
neuromodulation
techniques
that
regulate
regional
brain
activities
have
been
used
to
treat
refractory
mood
disorders.
However,
their
efficacy
varies
from
person
lack
reliable
indicator.
This
review
summarizes
clinical
animal
studies
on
inflammation
in
neural
circuits
related
anxiety
depression
evidence
therapies
neuroinflammation
treatment
neurological
diseases.
Neuromodulation
therapies,
including
transcranial
magnetic
stimulation
(TMS),
electrical
(TES),
electroconvulsive
therapy
(ECT),
photobiomodulation
(PBM),
ultrasound
(TUS),
deep
(DBS),
vagus
nerve
(VNS),
all
reported
attenuate
reduce
release
pro-inflammatory
factors,
which
may
be
one
reasons
for
improvement.
provides
a
better
understanding
effective
mechanism
indicates
inflammatory
biomarkers
serve
as
reference
assessment
pathological
conditions
options
depression.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(5), P. 2205 - 2231
Published: Jan. 1, 2022
Alzheimer's
disease
(AD)
is
the
most
common
form
of
dementia
in
elderly,
causing
neuronal
degeneration
and
cognitive
deficits
that
significantly
impair
independence
quality
life
for
those
affected
their
families.Though
AD
a
major
neurodegenerative
with
vast
avenues
investigation,
there
no
effective
treatment
to
cure
or
slow
progression.The
present
work
evaluated
therapeutic
effect
long-term
photobiomodulation
(PBM)
continuous-wave
low-level
laser
on
its
underlying
mechanism.Methods:
PBM
was
implemented
2
min,
3
times
per
week
16
months
2-month-old
transgenic
rats.A
battery
behavioral
tests
performed
measure
dysfunction
rats.The
effects
therapy
typical
pathologies,
including
amyloid
plaques,
intracellular
neurofibrillary
tangles,
loss,
injury,
apoptosis,
neurodegeneration,
were
then
assessed.The
mechanisms
measured
using
immunofluorescence
staining,
western
blotting
analysis,
mass
spectrometry,
primary
cortical
hippocampal
cell
cultures,
related
assay
kits.Results:
improved
pathologies
memory
tau
hyperphosphorylation,
degeneration,
spine
damage,
synaptic
loss.PBM
had
several
mechanistic
which
may
explain
these
beneficial
effects,
1)
regulation
glial
polarization
inhibition
neuroinflammation,
2)
preservation
mitochondrial
dynamics
by
regulating
fission
fusion
proteins,
3)
suppression
oxidative
damage
DNA,
lipids.Furthermore,
enhanced
recruitment
microglia
surrounding
plaques
improving
expression
microglial
IL-3Rα
astrocytic
IL-3,
implies
potential
role
Aβ
clearance.Finally,
our
results
implicate
hemoglobin
mediating
neuroprotective
PBM,
as
Hbα
knockdown
abolished
treatment.Conclusion:
Collectively,
data
supports
use
prevent
progression
provides
new
insights
into
molecular
therapy.
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(10), P. 3434 - 3450
Published: Jan. 1, 2023
Background:
Alzheimer's
disease
(AD),
one
of
the
most
common
forms
dementia,
is
a
widely
studied
neurodegenerative
characterized
by
Aβ
accumulation
and
tau
hyperphosphorylation.
Currently,
there
no
effective
cure
available
for
AD.The
astrocyte
AQP4
polarized
distribution-mediated
glymphatic
system
essential
abnormal
clearance
potential
therapeutic
target
AD.However,
role
exercise
on
distribution
association
between
phenotype
polarization
are
poorly
understood.Methods:
Using
streptozotocin
(STZ)-induced
sporadic
AD
rat
model,
we
investigated
effects
high-intensity
interval
training
pathologies.The
Branes
maze
task
was
conducted
to
measure
spatial
learning
memory.Immunofluorescence
staining
NeuN
with
TUNEL,
Fluoro-Jade
C,
relative
neuronal
damage
markers
applied
apoptosis,
neurodegeneration,
damage.Sholl
analysis
carried
out
analyze
morphology
microglia.Line-scan
analysis,
3D
rendering,
orthogonal
view
were
colocalization.Western
blot
enzyme-linked
immunosorbent
assay
(ELISA)
examine
Aβ,
respectively.An
APP/PS1
transgenic
mice
model
used
confirm
key
findings.Results:
High-intensity
(HIIT)
alleviates
cognitive
dysfunction
in
STZ-induced
AD-like
models
provides
neuroprotection
against
damage,
loss.Additionally,
HIIT
improved
drainage
from
cortex
hippocampus
via
kidney.Further
mechanistic
studies
support
that
beneficial
might
be
due,
part,
glial
cells
neurotoxic
towards
neuroprotective
phenotype.Furthermore,
an
intriguing
finding
our
study
strongly
correlated
phenotype.We
found
A2
exhibited
more
evident
than
A1
phenotype.
Conclusion:Our
findings
indicate
ameliorates
disease-like
pathology
regulating
phenotype-associated
polarization.These
changes
promote
p-tau
brain
tissue
through
kidney.
Inflammation and Regeneration,
Journal Year:
2022,
Volume and Issue:
42(1)
Published: Oct. 3, 2022
Abstract
Alzheimer’s
disease
(AD)
is
one
of
the
major
neurodegenerative
diseases
and
most
common
form
dementia.
Characterized
by
loss
learning,
memory,
problem-solving,
language,
other
thinking
abilities,
AD
exerts
a
detrimental
effect
on
both
patients’
families’
quality
life.
Although
there
have
been
significant
advances
in
understanding
mechanism
underlying
pathogenesis
progression
AD,
no
cure
for
AD.
The
failure
numerous
molecular
targeted
pharmacologic
clinical
trials
leads
to
an
emerging
research
shift
toward
non-invasive
therapies,
especially
multiple
treatments.
In
this
paper,
we
reviewed
widely
studied
including
photobiomodulation
(PBM),
transcranial
magnetic
stimulation
(TMS),
direct
current
(tDCS),
exercise
therapy.
Firstly,
pathological
changes
challenges
studies.
We
then
introduced
these
therapies
discussed
factors
that
may
affect
effects
therapies.
Additionally,
review
possible
mechanisms
effects.
Finally,
summarized
treatments
future
studies
applications.
concluded
it
would
be
critical
understand
exact
find
optimal
treatment
parameters
improve
translational
value
Moreover,
combined
use
also
promising
direction
sheds
light
or
prevention
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Feb. 22, 2023
Abstract
Cognitive
function
is
an
important
ability
of
the
brain,
but
cognitive
dysfunction
can
easily
develop
once
brain
injured
in
various
neuropathological
conditions
or
diseases.
Photobiomodulation
therapy
a
type
noninvasive
physical
that
gradually
emerging
field
neuroscience.
Transcranial
photobiomodulation
has
been
commonly
used
to
regulate
neural
activity
superficial
cortex.
To
stimulate
deeper
activity,
advanced
techniques
conjunction
with
photosensitive
nanoparticles
have
developed.
This
review
addresses
mechanisms
on
neurons
and
networks
discusses
advantages,
disadvantages
potential
applications
alone
combination
nanoparticles.
its
associated
strategies
may
provide
new
breakthrough
treatments
for
improvement.
Translational Psychiatry,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 11, 2025
Repeated
closed-head
injuries
(rCHI)
from
activities
like
contact
sports,
falls,
military
combat,
and
traffic
accidents
pose
a
serious
risk
due
to
their
cumulative
impact
on
the
brain.
Often,
rCHI
is
not
diagnosed
until
symptoms
of
irreversible
brain
damage
appear,
highlighting
need
for
preventive
measures.
This
study
assessed
prophylactic
efficacy
remote
photobiomodulation
(PBM)
targeted
at
lungs
against
rCHI-induced
injury
associated
behavioral
deficits.
Utilizing
"Marmarou"
weight-drop
model,
was
induced
in
rats
days
0,
5,
10.
Remote
PBM,
employing
an
808
nm
continuous
wave
laser,
administered
daily
2-min
sessions
per
lung
side
over
20
days.
Behavioral
deficits
were
through
three-chamber
social
interaction,
forced
swim,
grip
strength,
open
field,
elevated
plus
maze,
Barnes
maze
tests.
Immunofluorescence
staining
3D
reconstruction
evaluated
neuronal
damage,
apoptosis,
degeneration,
morphology
microglia
astrocytes,
as
well
astrocyte
microglia-mediated
excessive
synapse
elimination.
Additionally,
16S
rDNA
amplicon
sequencing
analyzed
changes
microbiome
following
PBM
treatment.
Results
demonstrated
that
significantly
improved
depressive-like
behaviors,
motor
dysfunction,
interaction
impairment
while
enhancing
strength
reducing
degeneration
by
rCHI.
Analysis
revealed
enrichment
lipopolysaccharide
(LPS)
biosynthesis
pathways,
suggesting
potential
link
neuroprotection.
Furthermore,
mitigated
hyperactivation
cortical
astrocytes
reduced
synaptic
phagocytosis
these
cells,
its
strategy
with
neuroprotective
effects.
Frontiers in Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: Sept. 20, 2022
Neuroinflammation
is
a
response
that
involves
different
cell
lineages
of
the
central
nervous
system,
such
as
neurons
and
glial
cells.
Among
non-pharmacological
interventions
for
neuroinflammation,
photobiomodulation
(PBM)
gaining
prominence
because
its
beneficial
effects
found
in
experimental
brain
research.
We
systematically
reviewed
PBM
on
laboratory
animal
models,
specially
to
investigate
potential
benefits
an
efficient
anti-inflammatory
therapy.We
conducted
systematic
search
bibliographic
databases
(PubMed
ScienceDirect)
with
keywords
based
MeSH
terms:
photobiomodulation,
low-level
laser
therapy,
brain,
inflammation,
cytokine,
microglia.
Data
was
limited
from
2009
June
2022.
followed
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
(PRISMA)
guideline.
The
initial
identified
140
articles.
them,
54
articles
were
removed
duplication
59
by
screening.
Therefore,
27
studies
met
inclusion
criteria.The
showed
has
properties
several
conditions,
traumatic
injury,
edema
formation
hyperalgesia,
ischemia,
neurodegenerative
aging,
epilepsy,
depression,
spinal
cord
injury.Taken
together,
these
results
indicate
transcranial
therapy
promising
strategy
treat
pathological
conditions
induced
neuroinflammation.
Cell & Bioscience,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Jan. 12, 2023
Temporal
lobe
epilepsy
(TLE)
remains
one
of
the
most
drug-resistant
focal
epilepsies.
Glutamate
excitotoxicity
and
neuroinflammation
which
leads
to
loss
synaptic
proteins
neuronal
death
appear
represent
a
pathogen
that
characterizes
neurobiology
TLE.
Photobiomodulation
(PBM)
is
rapidly
growing
therapy
for
attenuation
degeneration
harboring
non-invasiveness
benefits.
However,
detailed
effects
PBM
on
or
remain
unclear.
We
investigated
whether
tPBM
exerts
neuroprotective
hippocampal
neurons
in
mouse
model
by
regulating
synapse
synapse-related
genes.In
an
vitro
study,
we
performed
imaging
analysis
western
blot
primary
from
embryonic
(E17)
rat
pups.
In
vivo
RNA
sequencing
was
identify
gene
regulatory
PBM.
Histological
stain
immunohistochemistry
analyses
were
used
assess
connections,
survival.
Behavioral
tests
evaluate
cognitive
functions.PBM
upregulated
connections
vitro.
addition,
it
confirmed
transcranial
reduced
degeneration,
apoptosis,
vivo.
These
supported
results
showing
relation
with
networks
functions.
Specifically,
Nlgn3
showed
increase
after
silencing
reversed
positive
effect
Lastly,
behavioral
alterations
including
hypoactivity,
anxiety
impaired
memory
recovered
along
reduction
seizure
score
PBM-treated
mice.Our
findings
demonstrate
attenuates
epileptic
excitotoxicity,
neurodegeneration
decline
induced
TLE
through
inhibition
decrease
excitotoxicity.